Benneh Charles Kwaku, Abotsi Wonder Kofi Mensah, Mante Priscilla Kolibea, Biney Robert Peter, Fetse John Peter, Abeka Mustapha Kobina, Adongo Donatus Wewura, Woode Eric
Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, UK.
Department of Pharmacology and Toxicology, School of Pharmacy, University of Health and Allied Sciences, Ho, Ghana.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan 28. doi: 10.1007/s00210-025-03814-8.
Major depressive disorder is one of the most common and burdensome psychiatric disorders worldwide. This study evaluated the anxiolytic- and antidepressant-like activity of three semi-synthetic derivatives of xylopic acid (XA) to identify the most promising derivative based on mechanism(s) of action, in vivo pharmacokinetics and in vitro cytotoxicity.
The anxiolytic potential and the involvement of GABAergic mechanisms were assessed in the elevated plus-maze and open field tests in mice. The antidepressant-like effects were also investigated in the tail suspension test (TST) and forced swim test (FST). Possible mechanism(s) of antidepressant-effect was assessed by selective depletion of monoamines, using either reserpine, alpha-methyl-para-tyrosine or para-chlorophenylalanine (pCPA) prior to repeating the TST and FST. A single oral (100 mg kg) and intravenous bolus dose (100 mg kg) of XA or deacetylated XA (dXA) was administered separately to mice and the plasma concentration of each compound subjected to non-compartmental analyses. The potential cytotoxic effect of XA and dXA was also assessed with the MTT assay using HepG2 and Caco-2 cells.
XA and all the derivatives (10-100 mg kg) reduced anxiety- and depression-related behaviours. The anxiolytic-like effect of dXA was attenuated by pentylenetetrazole while its antidepressant-like properties were reversed in reserpine and pCPA pre-treated mice. In comparison to XA, dXA had lower oral clearance, longer half-life, shorter time to reach peak plasma concentration and was less toxic to hepG2 cells.
All the semi-synthetic derivatives of XA exert varying degrees of anxiolytic- and antidepressant-like effects in mice. The anxiolytic- and antidepressant-like effects of dXA and XA are mediated, at least partly, through GABAergic and serotoninergic systems, respectively. In comparison with XA, dXA has a much lower clearance, longer half-life, shorter time to reach peak plasma concentration and was less toxic to HepG2 cells.
重度抑郁症是全球最常见且负担沉重的精神疾病之一。本研究评估了三种木瓣酸(XA)半合成衍生物的抗焦虑和抗抑郁样活性,以便根据作用机制、体内药代动力学和体外细胞毒性确定最有前景的衍生物。
在小鼠高架十字迷宫和旷场试验中评估抗焦虑潜力及GABA能机制的参与情况。还在悬尾试验(TST)和强迫游泳试验(FST)中研究抗抑郁样作用。在重复TST和FST之前,通过使用利血平、α-甲基对酪氨酸或对氯苯丙氨酸(pCPA)选择性耗竭单胺来评估抗抑郁作用的可能机制。分别给小鼠单次口服(100 mg/kg)和静脉推注剂量(100 mg/kg)的XA或去乙酰化XA(dXA),并对每种化合物的血浆浓度进行非房室分析。还使用MTT法,以HepG2和Caco-2细胞评估XA和dXA的潜在细胞毒性作用。
XA和所有衍生物(10 - 100 mg/kg)均减少了与焦虑和抑郁相关的行为。dXA的抗焦虑样作用被戊四氮减弱,而其抗抑郁样特性在利血平和pCPA预处理的小鼠中被逆转。与XA相比,dXA的口服清除率较低、半衰期较长、达到血浆峰浓度的时间较短,且对HepG2细胞的毒性较小。
XA的所有半合成衍生物在小鼠中均发挥不同程度的抗焦虑和抗抑郁样作用。dXA和XA的抗焦虑和抗抑郁样作用至少部分分别通过GABA能和5-羟色胺能系统介导。与XA相比,dXA的清除率低得多、半衰期长、达到血浆峰浓度的时间短,且对HepG2细胞的毒性较小。